BioMarin Pharmaceutical
BMRN
#1746
Rank
โ‚ฌ10.84 B
Marketcap
55,97ย โ‚ฌ
Share price
-0.02%
Change (1 day)
23.33%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2026 (TTM): โ‚ฌ36.33 Million

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are โ‚ฌ3.65 Billion. In 2025 the company made an earning of โ‚ฌ0.43 Billion a decrease over its 2024 earnings that were of โ‚ฌ0.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ36.33 M-91.74%
2025 โ‚ฌ0.43 B-10.94%
2024 โ‚ฌ0.49 B187.31%
2023 โ‚ฌ0.17 B26.07%
2022 โ‚ฌ0.13 B-298.51%
2021 -โ‚ฌ68.67 Million78.04%
2020 -โ‚ฌ38.57 Million-55.36%
2019 -โ‚ฌ86.41 Million-33.56%
2018 -โ‚ฌ0.14 Billion297.78%
2017 -โ‚ฌ32.7 Million-95.68%
2016 -โ‚ฌ0.76 Billion437.12%
2015 -โ‚ฌ0.15 Billion23.91%
2014 -โ‚ฌ0.12 Billion-29.25%
2013 -โ‚ฌ0.17 Billion49.23%
2012 -โ‚ฌ0.11 Billion171.11%
2011 -โ‚ฌ39.76 Million103.01%
2010 -โ‚ฌ19.59 Million-3903.54%
2009 โ‚ฌ0.51 M-98.31%
2008 โ‚ฌ30.45 M-189.7%
2007 -โ‚ฌ33.96 Million51.02%
2006 -โ‚ฌ22.49 Million-61.58%
2005 -โ‚ฌ58.52 Million-56.59%
2004 -โ‚ฌ0.14 Billion95.13%
2003 -โ‚ฌ69.08 Million12.09%
2002 -โ‚ฌ61.63 Million73.19%
2001 -โ‚ฌ35.59 Million18.32%
2000 -โ‚ฌ30.08 Million19.65%
1999 -โ‚ฌ25.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
โ‚ฌ7.09 B 17,735.86%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-โ‚ฌ0.41 Billion-1,124.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚ฌ0.11 Billion-352.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚ฌ72.34 M 81.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚ฌ0.17 M-99.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚ฌ0.27 B 578.94%๐Ÿ‡บ๐Ÿ‡ธ USA